Analytical Development & Quality Control Director
US$194,000 – US$233,000 / yr base salary
Posted 27 Aug 2026
Advertised as “Director, Analytical Development & Quality Control ”
BranchFactor Summary
The original posting with the fluff stripped out
- Expected experience
- 12+ yrs
- Management level
- People management
| Base salary | US$194,000 – US$233,000 / yr |
|---|
Field of studyAnalytical Chemistry, Biochemistry, Biotechnology, Chemical Engineering, Pharmaceutical Sciences (or related)
Study levelMaster's or higher
Position Summary
The Director of Analytical Development & Quality Control will provide strategic and operational leadership for analytical development, characterization, method validation, transfer, and quality control activities supporting a growing pipeline of small molecule Oral Solid Dose (OSD) and parenteral Drug Product programs. The incumbent will have deep experience in analytical activities required to support early-stage to late-stage oral solid dose and parenteral drug products. Additional experience in antibody/ADC manufacturing-focused analytical activities is desirable. This individual will be responsible for operating in a 100% outsourced environment to establish and manage phase-appropriate analytical strategies from preclinical through commercialization, overseeing external analytical operations, and ensuring compliance with global regulatory expectations and GMP requirements for assigned programs.
As a key member of the Technical Operations team, the Director will collaborate cross-functionally with Medicinal Chemistry, Toxicology, Clinical Pharmacology, Drug Substance, Drug Product, ADC production, Regulatory Affairs, Quality Assurance, and external CDMOs/CRO/consultants to advance programs efficiently through development milestones while building scalable analytical and quality control capabilities for a rapidly growing organization.
Key Responsibilities
Analytical Development Leadership
-
Lead, develop and execute phase-appropriate analytical method development and testing strategies and activities supporting Drug Product development, with an emphasis on small-molecule OSD and large-molecule parenteral Drug Product analytical method development and testing for assigned programs, including:
-
Phase-appropriate small molecule oral solid dose drug product method development and testing (tablets, capsules, gelcaps)
-
Phase-appropriate method development supporting antibody manufacture, ADC conjugation, and parenteral drug product manufacture.
-
Provide technical oversight for development, qualification, validation, and lifecycle management of analytical methods.
-
Ensure analytical methods support process development, formulation development, manufacturing, release testing, and regulatory submissions.
-
Depending on experience, incumbent may serve as the company's analytical subject matter expert for ADC development.
-
Support characterization of monoclonal antibodies, cytotoxic payloads, linkers, conjugates, and related impurities.
-
Guide implementation and interpretation of advanced analytical techniques such as: HPLC, UPLC, LC-MS, HRMS, SEC, CE-SDS, icIEF, HIC, ELISA, and bioassays.